DEF 14C

DEF 14C Filing

Company: Processa Pharmaceuticals, Inc.
Filed: May 27, 2020
Period of Report: May 27, 2020
Accession Number: 0001493152-20-009937

View Document ↗ View on SEC.gov ↗